Caitong International Asset Management Co., LTD Immunome Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Immunome Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 191 shares of IMNM stock, worth $1,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
191
Previous 106
80.19%
Holding current value
$1,675
Previous $1.13 Million
14.12%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
149Shares Held
66.4MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$66.3 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$47 Million3.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.36MShares$38.2 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$37.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$35.8 Million2.16% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $106M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...